Compare REED & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | REED | OSRH |
|---|---|---|
| Founded | 1987 | N/A |
| Country | United States | United States |
| Employees | 44 | 22 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.1M | 17.9M |
| IPO Year | N/A | N/A |
| Metric | REED | OSRH |
|---|---|---|
| Price | $1.01 | $0.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 20.1K | ★ 549.9K |
| Earning Date | 05-12-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.74 | $9.30 |
| Revenue Next Year | $18.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.03 | $0.30 |
| 52 Week High | $5.97 | $1.24 |
| Indicator | REED | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 28.24 | 48.26 |
| Support Level | N/A | $0.30 |
| Resistance Level | $1.42 | $0.45 |
| Average True Range (ATR) | 0.15 | 0.03 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 0.00 | 76.69 |
Reed's Inc is a branded beverage company offering a portfolio of natural, premium, and functional beverages under the Reed's and Virgil's brands. The company's portfolio of handcrafted, all-natural beverages is sold in outlets nationwide, including the natural and specialty food channel, grocery stores, mass merchants, drug stores, convenience stores, club stores, and on-premise locations, including bars and restaurants. The company operates in a single reportable segment, which consists of manufacturing carbonated beverages under Reed's and Virgil's brand names.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. The company's pipeline products include: Vaximm, Darnatein, Woori IO, and RMC.